LifeMD Secures New Revolving Credit Facility for Growth

LifeMD ( (LFMD) ) just unveiled an announcement.

On January 2, 2026, LifeMD, Inc. entered into a senior secured revolving credit agreement with Citizens Bank, N.A. that provides a committed $30 million credit facility, with an accordion option to increase total availability to $50 million, maturing on January 2, 2029. The facility, which carries no upfront fee, is priced on a leverage-based grid using either Term SOFR plus 1.50%–2.25% or an Alternate Base Rate plus 0.50%–1.25%, with commitment fees of 0.225%–0.30% on unused amounts, and is backed by pledge, security and guarantee agreements from LifeMD and its subsidiaries. As of the January 2, 2026 closing, LifeMD had not drawn on the facility, indicating that existing cash and expected cash flow are currently sufficient to fund organic growth, while the new revolving line enhances the company’s financial flexibility for potential corporate development and shareholder value initiatives and subjects it to leverage and interest coverage covenants that will help shape its capital structure and growth strategy going forward.

The most recent analyst rating on (LFMD) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on LifeMD stock, see the LFMD Stock Forecast page.

Spark’s Take on LFMD Stock

According to Spark, TipRanks’ AI Analyst, LFMD is a Neutral.

The score is primarily held down by weak financial quality in the provided statements (net losses/low operating margins and high leverage) and a bearish longer-term technical trend (below key moving averages with negative MACD). Offsetting this, the latest earnings call provided relatively strong growth/adjusted EBITDA guidance and strategic momentum, while valuation offers limited support due to a negative P/E and no dividend yield data.

To see Spark’s full report on LFMD stock, click here.

More about LifeMD

LifeMD, Inc. is a leading provider of virtual primary care and pharmacy services, offering telemedicine, laboratory and pharmacy access, and specialized treatment for more than 200 conditions, including primary care, men’s and women’s health, weight management and hormone therapy. The company operates a vertically integrated digital care platform supported by a 50-state affiliated medical group, an affiliated compounding pharmacy and a U.S.-based patient care center, with a focus on expanding access to affordable, high-quality healthcare across the United States.

Average Trading Volume: 1,260,554

Technical Sentiment Signal: Sell

Current Market Cap: $188.2M

Learn more about LFMD stock on TipRanks’ Stock Analysis page.